Format

Send to

Choose Destination
Eur J Immunol. 2009 Apr;39(4):931-8. doi: 10.1002/eji.200839035.

Enhancing immune responses by targeting antigen to DC.

Author information

1
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. caminschi@wehi.edu.au

Abstract

mAb that recognise various cell surface receptors have been used to deliver antigen to DC and thereby elicit immune responses. The encouraging data obtained in mouse models suggests that this immunisation strategy is efficient and could lead to clinical trials. We discuss a number of issues pertinent to this vaccination approach. These include which molecules are the best targets for delivering antigen to DC, which DC subtypes should be targeted, the types of immune responses to be generated and whether additional adjuvants are required. Finally, we discuss some progress towards targeting antigen to human DC.

PMID:
19197943
DOI:
10.1002/eji.200839035
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center